Level Biotechnology Past Earnings Performance
Past criteria checks 2/6
Level Biotechnology has been growing earnings at an average annual rate of 8.2%, while the Healthcare industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 0.6% per year. Level Biotechnology's return on equity is 11.4%, and it has net margins of 9.5%.
Key information
8.2%
Earnings growth rate
8.2%
EPS growth rate
Healthcare Industry Growth | 9.1% |
Revenue growth rate | -0.6% |
Return on equity | 11.4% |
Net Margin | 9.5% |
Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Some Investors May Be Worried About Level Biotechnology's (GTSM:3118) Returns On Capital
Apr 27Calculating The Fair Value Of Level Biotechnology Inc. (GTSM:3118)
Mar 16Here's What You Should Know About Level Biotechnology Inc.'s (GTSM:3118) 3.6% Dividend Yield
Feb 14Does Level Biotechnology's (GTSM:3118) Returns On Capital Reflect Well On The Business?
Jan 24Level Biotechnology Inc.'s (GTSM:3118) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Jan 03Calculating The Intrinsic Value Of Level Biotechnology Inc. (GTSM:3118)
Dec 16Here's Why We Think Level Biotechnology's (GTSM:3118) Statutory Earnings Might Be Conservative
Nov 28Revenue & Expenses BreakdownBeta
How Level Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 661 | 63 | 138 | 14 |
30 Sep 23 | 654 | 60 | 132 | 14 |
30 Jun 23 | 633 | 62 | 130 | 14 |
31 Mar 23 | 620 | 64 | 126 | 14 |
31 Dec 22 | 593 | 58 | 124 | 14 |
30 Sep 22 | 569 | 57 | 127 | 14 |
30 Jun 22 | 601 | 62 | 130 | 15 |
31 Mar 22 | 632 | 61 | 136 | 15 |
31 Dec 21 | 677 | 68 | 139 | 15 |
30 Sep 21 | 728 | 74 | 138 | 15 |
30 Jun 21 | 716 | 70 | 135 | 14 |
31 Mar 21 | 701 | 69 | 133 | 14 |
31 Dec 20 | 672 | 58 | 132 | 14 |
30 Sep 20 | 648 | 50 | 129 | 14 |
30 Jun 20 | 641 | 48 | 127 | 13 |
31 Mar 20 | 635 | 47 | 125 | 14 |
31 Dec 19 | 639 | 47 | 126 | 14 |
30 Sep 19 | 646 | 47 | 124 | 14 |
30 Jun 19 | 651 | 45 | 124 | 15 |
31 Mar 19 | 644 | 41 | 124 | 15 |
31 Dec 18 | 629 | 39 | 123 | 14 |
30 Sep 18 | 619 | 46 | 124 | 13 |
30 Jun 18 | 579 | 45 | 121 | 12 |
31 Mar 18 | 583 | 57 | 118 | 11 |
31 Dec 17 | 578 | 68 | 115 | 12 |
30 Sep 17 | 543 | 72 | 111 | 12 |
30 Jun 17 | 537 | 75 | 109 | 13 |
31 Mar 17 | 512 | 65 | 107 | 14 |
31 Dec 16 | 514 | 63 | 106 | 14 |
30 Sep 16 | 504 | 61 | 105 | 14 |
30 Jun 16 | 523 | 69 | 104 | 14 |
31 Mar 16 | 530 | 78 | 105 | 15 |
31 Dec 15 | 520 | 78 | 103 | 15 |
30 Sep 15 | 540 | 85 | 104 | 15 |
30 Jun 15 | 524 | 80 | 104 | 15 |
31 Mar 15 | 526 | 77 | 102 | 14 |
31 Dec 14 | 533 | 77 | 104 | 14 |
30 Sep 14 | 515 | 71 | 100 | 14 |
30 Jun 14 | 535 | 70 | 100 | 15 |
31 Mar 14 | 527 | 66 | 101 | 16 |
31 Dec 13 | 529 | 65 | 99 | 17 |
30 Sep 13 | 516 | 59 | 97 | 18 |
30 Jun 13 | 493 | 55 | 96 | 18 |
Quality Earnings: 3118 has high quality earnings.
Growing Profit Margin: 3118's current net profit margins (9.5%) are lower than last year (9.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3118's earnings have grown by 8.2% per year over the past 5 years.
Accelerating Growth: 3118's earnings growth over the past year (7.6%) is below its 5-year average (8.2% per year).
Earnings vs Industry: 3118 earnings growth over the past year (7.6%) did not outperform the Healthcare industry 7.6%.
Return on Equity
High ROE: 3118's Return on Equity (11.4%) is considered low.